The in vivo effect of the administration of resistance-modulating agents on rhodamine 123 distribution in mice thymus and lymph nodes
Authors:
- Luis F Marques-SantosLMLuis F Marques-Santos
- Ramza C HarabRHRamza C Harab
- Emı́lio F de PaulaEPEmı́lio F de Paula
- Vivian M RumjanekVRVivian M Rumjanek
- 1 March 1999
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 137 (1) , 99-106
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Flow cytometric analysis of P-glycoprotein function using rhodamine 123Leukemia, 1997
- Flow cytometric analysis of the multiple drug resistance phenotypeLeukemia, 1997
- Altered Pharmacokinetics of Vinblastine in Mdr1a P-glycoprotein-Deficient MiceJNCI: Journal of the National Cancer Institute, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Phosphatidylcholine translocase: A physiological role for the mdr2 geneCell, 1994
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences, 1989
- Use of fluorescent dyes as molecular probes for the study of multidrug resistanceExperimental Cell Research, 1988